These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3137609)

  • 1. Apomorphine-induced limb flicks in cats: the role of dopamine receptors located outside the blood-brain barrier.
    Stewart BR; Broekkamp CL
    Psychopharmacology (Berl); 1988; 95(2):268-70. PubMed ID: 3137609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bromocriptine and apomorphine stimulation of cortisol secretion in conscious dogs; evidence for a stimulatory site located outside the blood brain barrier.
    Goiny M; Uvnäs-Moberg K; Cekan S
    Psychopharmacology (Berl); 1986; 89(1):108-12. PubMed ID: 3090584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of domperidone on apomorphine-induced growth hormone secretion in normal men.
    Lal S; Nair NP; Iskandar HL; Etienne P; Wood PL; Schwartz G; Guyda H
    J Neural Transm; 1982; 54(1-2):75-84. PubMed ID: 7108512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple receptors for brain dopamine in behavior regulation: concept of dopamine-E and dopamine-I receptors.
    Cools AR; van Rossum JM
    Life Sci; 1980 Oct; 27(14):1237-53. PubMed ID: 6255271
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of metoclopramide, domperidone and apomorphine on GH secretion in children and adolescents.
    Massara F; Tangolo D; Godano A; Goffi S; Bertagna A; Molinatti GM
    Acta Endocrinol (Copenh); 1985 Apr; 108(4):451-5. PubMed ID: 3993312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of dopamine receptor antagonists on gastrin and vomiting responses to apomorphine.
    Goiny M; Uvnäs-Moberg K
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Jul; 336(1):16-9. PubMed ID: 2888024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of dopamine autoreceptor agonist properties of apomorphine, (+)-3-PPP and (-)-3-PPP by recording of yawning behaviour in rats.
    Ståhle L; Ungerstedt U
    Eur J Pharmacol; 1984 Feb; 98(2):307-10. PubMed ID: 6714314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonergic and dopaminergic effects of yawning in the cat.
    Marini JL
    Pharmacol Biochem Behav; 1981 Nov; 15(5):711-5. PubMed ID: 7312907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of drugs acting on central dopamine receptors and cholinoceptors on yawning responses in the rat induced by apomorphine, bromocriptine or physostigmine.
    Zarrindast MR; Poursoltan M
    Br J Pharmacol; 1989 Apr; 96(4):843-8. PubMed ID: 2663110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apomorphine and haloperidol, but not domperidone, affect penile reflexes in rats.
    Pehek EA; Thompson JT; Eaton RC; Bazzett TJ; Hull EM
    Pharmacol Biochem Behav; 1988 Sep; 31(1):201-8. PubMed ID: 3252251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification by domperidone of dopamine- and apomorphine-induced inhibition of extrinsic ruminal contractions in goats.
    Maas CL; van Duin CT; van Miert AS
    J Vet Pharmacol Ther; 1982 Sep; 5(3):191-4. PubMed ID: 7143556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for a dopamine interaction with the central respiratory control system in the rat.
    Hedner J; Hedner T; Jonason J; Lundberg D
    Eur J Pharmacol; 1982 Jul; 81(4):603-15. PubMed ID: 6811296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible anomalous behaviour of apomorphine in relation to other dopamine receptor agonists.
    Feenstra MG; Goedemoed JH; Rollema H; Horn AS
    J Pharm Pharmacol; 1983 Jul; 35(7):471-3. PubMed ID: 6136595
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of the D1 receptor agonist SKF 38393 on some behavioural effects of apomorphine in rats.
    Zarkovsky AM; Cereska KS
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Apr; 339(4):383-6. PubMed ID: 2567965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure effects of intravenous apomorphine in conscious deoxycorticosterone-acetate salt-hypertensive rats.
    Toscano CF; Lahlou S
    J Cardiovasc Pharmacol; 2003 Dec; 42(6):772-81. PubMed ID: 14639100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic efficacy of apomorphine combined with an extracerebral inhibitor of dopamine receptors in Parkinson's disease.
    Corsini GU; Del Zompo M; Gessa GL; Mangoni A
    Lancet; 1979 May; 1(8123):954-6. PubMed ID: 87620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain implants in man do not break down the blood-brain barrier to dopamine and domperidone.
    Clough CG; Hitchcock ER; Hughes RC; Henderson BT; Kenny BG
    Brain Res; 1992 Sep; 589(2):E2-4. PubMed ID: 1393589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mescaline elicits behavioral effects in cats by an action at both serotonin and dopamine receptors.
    Trulson ME; Crisp T; Henderson LJ
    Eur J Pharmacol; 1983 Dec; 96(1-2):151-4. PubMed ID: 6581976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of the behavioral changes evoked by d-amphetamine and apomorphine in adult cats. Dose-response relationship.
    Motles E; Martinez I; Concha E; Mejias B; Torres P
    Pharmacol Biochem Behav; 1989 May; 33(1):115-21. PubMed ID: 2780770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interference between central dopaminergic stimulation, and adrenal secretion in normoxic or hypobaric hypoxic rats.
    Saligaut C; Moore N; Chretien P; Daoust M; Richard O; Boismare F
    Stroke; 1982; 13(6):859-64. PubMed ID: 7147306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.